Papanikolopoulou, A.; Rapti, V.; Alexiou, P.; Charalampous, C.M.; Livanou, M.E.; Sakka, V.; Syrigos, K.N.; Poulakou, G.
Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers of COVID-19 Disease Irrespective of Immunosuppression Status: A Case-Control Retrospective Single-Center Study. Pathogens 2025, 14, 550.
https://doi.org/10.3390/pathogens14060550
AMA Style
Papanikolopoulou A, Rapti V, Alexiou P, Charalampous CM, Livanou ME, Sakka V, Syrigos KN, Poulakou G.
Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers of COVID-19 Disease Irrespective of Immunosuppression Status: A Case-Control Retrospective Single-Center Study. Pathogens. 2025; 14(6):550.
https://doi.org/10.3390/pathogens14060550
Chicago/Turabian Style
Papanikolopoulou, Amalia, Vasiliki Rapti, Polyxeni Alexiou, Charalampos M. Charalampous, Maria Effrosyni Livanou, Vissaria Sakka, Konstantinos N. Syrigos, and Garyfallia Poulakou.
2025. "Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers of COVID-19 Disease Irrespective of Immunosuppression Status: A Case-Control Retrospective Single-Center Study" Pathogens 14, no. 6: 550.
https://doi.org/10.3390/pathogens14060550
APA Style
Papanikolopoulou, A., Rapti, V., Alexiou, P., Charalampous, C. M., Livanou, M. E., Sakka, V., Syrigos, K. N., & Poulakou, G.
(2025). Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) as Prognostic Markers of COVID-19 Disease Irrespective of Immunosuppression Status: A Case-Control Retrospective Single-Center Study. Pathogens, 14(6), 550.
https://doi.org/10.3390/pathogens14060550
